Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Using drugs to activate the Wnt/β-catenin pathway has potential for treating diseases but also presents challenges.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

Sesn2 protects inner ear hair cells from damage by regulating certain cell survival pathways.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

Impaired autophagy may contribute to alopecia areata.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Cow milk sugars increase fat production and inflammation in skin oil cells.

Understanding WNT signaling proteins can help predict and treat certain types of hair loss.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

Blocking a protein called CXXC5 with a specific peptide can stimulate hair regrowth and new hair growth in wounds.

High energy boosts root hair growth in plants, while low energy stops it.

Heat stress reduced hair growth and affected related genes in rex rabbits.

Key proteins affecting cashmere fiber quality were identified for better breeding.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

rRSPO1 protein boosts hair growth by activating a key signaling pathway.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Hairless protein reduces Msx2 gene activity, affecting hair follicle development.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.